SG11201506197TA - Combination vaccine for respiratory syncytial virus and influenza - Google Patents

Combination vaccine for respiratory syncytial virus and influenza

Info

Publication number
SG11201506197TA
SG11201506197TA SG11201506197TA SG11201506197TA SG11201506197TA SG 11201506197T A SG11201506197T A SG 11201506197TA SG 11201506197T A SG11201506197T A SG 11201506197TA SG 11201506197T A SG11201506197T A SG 11201506197TA SG 11201506197T A SG11201506197T A SG 11201506197TA
Authority
SG
Singapore
Prior art keywords
influenza
respiratory syncytial
syncytial virus
combination vaccine
vaccine
Prior art date
Application number
SG11201506197TA
Other languages
English (en)
Inventor
Gale E Smith
Greg Glenn
Lou Fries
James F Young
Original Assignee
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novavax Inc filed Critical Novavax Inc
Publication of SG11201506197TA publication Critical patent/SG11201506197TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SG11201506197TA 2013-02-11 2014-02-11 Combination vaccine for respiratory syncytial virus and influenza SG11201506197TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361763309P 2013-02-11 2013-02-11
US201361875327P 2013-09-09 2013-09-09
PCT/US2014/015725 WO2014124423A1 (en) 2013-02-11 2014-02-11 Combination vaccine for respiratory syncytial virus and influenza

Publications (1)

Publication Number Publication Date
SG11201506197TA true SG11201506197TA (en) 2015-09-29

Family

ID=50185053

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201506197TA SG11201506197TA (en) 2013-02-11 2014-02-11 Combination vaccine for respiratory syncytial virus and influenza

Country Status (13)

Country Link
US (1) US20140227309A1 (he)
EP (1) EP2953642A1 (he)
JP (1) JP2016509015A (he)
KR (1) KR20150138184A (he)
CN (1) CN105101992A (he)
AU (1) AU2014214590A1 (he)
BR (1) BR112015019126A2 (he)
CA (1) CA2900489A1 (he)
IL (1) IL240504A0 (he)
MX (1) MX2015010305A (he)
RU (1) RU2015138530A (he)
SG (1) SG11201506197TA (he)
WO (1) WO2014124423A1 (he)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11446374B2 (en) 2008-12-09 2022-09-20 Novavax, Inc. Modified RSV F proteins and methods of their use
EP3718566B1 (en) 2008-12-09 2024-06-12 Novavax, Inc. Modified rsv f proteins and methods of their use
US9504743B2 (en) 2013-09-25 2016-11-29 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149522B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US20150086592A1 (en) 2013-09-25 2015-03-26 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149521B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US10220086B2 (en) 2014-12-19 2019-03-05 Oregon Health & Science University Synergistic co-administration of computationally optimized broadly reactive antigens for H1N1 influenza
US10426829B2 (en) 2015-09-03 2019-10-01 Novavax, Inc. Vaccine compositions having improved stability and immunogenicity
CN106822887A (zh) * 2017-01-26 2017-06-13 中国科学院微生物研究所 一种流感病毒四价亚单位疫苗及其应用
CN107961371B (zh) * 2017-04-19 2020-08-11 武汉博沃生物科技有限公司 季节流感-rsv联合疫苗及其制备方法和应用
KR20210004959A (ko) 2018-03-19 2021-01-13 노바백스, 인코포레이티드 다가 인플루엔자 나노입자 백신
CN110559434B (zh) * 2018-06-05 2022-08-19 普莱柯生物工程股份有限公司 一种禽流感病毒样颗粒疫苗、及其制备方法和应用
EP4143576A1 (en) * 2020-05-01 2023-03-08 Meso Scale Technologies, LLC Viral serology assays
WO2024089634A1 (en) * 2022-10-27 2024-05-02 Pfizer Inc. Immunogenic compositions against influenza and rsv
WO2024127181A1 (en) * 2022-12-11 2024-06-20 Pfizer Inc. Immunogenic compositions against influenza and rsv

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01006214A (es) * 1998-12-17 2004-09-06 Aventis Pasteur Composicion inmunogenica multivalente que contiene una preparacion de virus de influenza y una composicion de subunidad del virus sincicial respiratorio.
JP2010522540A (ja) * 2007-03-21 2010-07-08 アイディー バイオメディカル コーポレイション オブ ケベック キメラ抗原
SI2540312T1 (sl) * 2007-07-19 2015-08-31 Novavax, Inc. Ptičji influenčni himerni VLP
EP3718566B1 (en) * 2008-12-09 2024-06-12 Novavax, Inc. Modified rsv f proteins and methods of their use

Also Published As

Publication number Publication date
EP2953642A1 (en) 2015-12-16
KR20150138184A (ko) 2015-12-09
AU2014214590A1 (en) 2015-08-27
US20140227309A1 (en) 2014-08-14
RU2015138530A (ru) 2017-03-20
CN105101992A (zh) 2015-11-25
WO2014124423A1 (en) 2014-08-14
JP2016509015A (ja) 2016-03-24
MX2015010305A (es) 2015-11-18
CA2900489A1 (en) 2014-08-14
BR112015019126A2 (pt) 2017-08-22
IL240504A0 (he) 2015-09-24

Similar Documents

Publication Publication Date Title
IL258831A (he) תרכיב וירוס סינסיציאלי נשימתי
IL261204A (he) חיסונים לוירוס האינפלואנזה ושימושם
IL240504A0 (he) חיסון משולב לוירוס נשימתי סינציאלי ואינפלואנזה
IL262123A (he) חיסונים לנגיף שפעת ושימושים בהם
SG10201801431TA (en) Respiratory syncytial virus (rsv) vaccine
HK1214962A1 (zh) 流感病毒免疫原性組合物及其應用
HK1223110A1 (zh) 流行性感冒病毒疫苗及其用途
ZA201700165B (en) Influenza virus vaccines and uses thereof
HK1199211A1 (en) Influenza virus vaccines and uses thereof
IL240936B (he) Reassortment של וירוס השפעת ושיטות להכנתם
EP2806891A4 (en) PARAIN FLUENZA VIRUS 5 BASED VACCINES
SG11201610443WA (en) Influenza virus vaccines and uses thereof
HK1219482A1 (zh) 基於喹唑啉的呼吸道合胞病毒抑制劑
HK1220656A1 (zh) 減弱的流感病毒和疫苗
IL244354B (he) חיסון שפעת וטיפול
EP3022298A4 (en) WAXED INFLUENZA VACCINE AND USES THEREOF
HK1223644A1 (zh) 呼吸道合胞病毒半活疫苗
EP3240568A4 (en) Recombinant influenza virus vaccines for influenza and respiratory syncytial virus
HK1223643A1 (zh) 呼吸道合胞病毒半活疫苗
HK1201283A1 (en) Influenza c virus and vaccine
LT3383428T (lt) Respiracinio sincitinio viruso vakcina
IL249705B (he) חיסונים נגד נגיף השפעת ושימושים בהם
IL249704A0 (he) חיסונים נגד נגיף השפעת ושימושים בהם